Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 6 | $80,740,767 |
| Sells | 37 | $12,378,820 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 07 Mar 2025 20:02 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 05 Mar 2025 | Sale | 1,590 | 30.48 | 48,463 | D |
| 07 Mar 2025 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 05 Mar 2025 | Sale | 7,326 | 29.98 | 219,633 | D |
| 07 Mar 2025 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 05 Mar 2025 | Sale | 2,674 | 30.62 | 81,878 | D |
| 07 Feb 2025 20:02 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 05 Feb 2025 | Sale | 3,520 | 40.69 | 143,229 | D |
| 07 Feb 2025 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 05 Feb 2025 | Sale | 15,000 | 40.58 | 608,700 | D |
| 10 Jan 2025 20:00 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 08 Jan 2025 | Sale | 12,132 | 48.72 | 591,071 | D |
| 10 Jan 2025 20:00 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 08 Jan 2025 | Sale | 2,868 | 49.38 | 141,622 | D |
| 03 Jan 2025 20:00 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 02 Jan 2025 | Sale | 1,499 | 46.42 | 69,584 | D |
| 03 Jan 2025 20:00 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 02 Jan 2025 | Sale | 2,486 | 47.21 | 117,364 | D |
| 03 Jan 2025 20:00 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 02 Jan 2025 | Sale | 100 | 47.92 | 4,792 | D |
| 16 Dec 2024 06:00 | APGE | Apogee Therapeutics Inc | MCKENNA MARK C. | Director | 12 Dec 2024 | Purchase | 7,500 | 49.02 | 367,650 | D |
| 16 Dec 2024 06:00 | APGE | Apogee Therapeutics Inc | MCKENNA MARK C. | Director | 12 Dec 2024 | Purchase | 12,500 | 49.85 | 623,125 | D |
| 13 Dec 2024 20:01 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 11 Dec 2024 | Sale | 4,085 | 48.62 | 198,613 | D |
| 13 Dec 2024 20:01 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 11 Dec 2024 | Sale | 455 | 50 | 22,750 | D |
| 06 Dec 2024 20:02 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 04 Dec 2024 | Sale | 6,665 | 46.07 | 307,057 | D |
| 06 Dec 2024 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 04 Dec 2024 | Sale | 13,328 | 46.5 | 619,752 | D |
| 06 Dec 2024 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 04 Dec 2024 | Sale | 1,672 | 47.19 | 78,902 | D |
| 08 Nov 2024 20:02 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 06 Nov 2024 | Sale | 5,326 | 58.91 | 313,755 | D |
| 08 Nov 2024 20:02 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 06 Nov 2024 | Sale | 1,339 | 59.96 | 80,286 | D |
| 08 Nov 2024 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 06 Nov 2024 | Sale | 14,000 | 59.17 | 828,380 | D |
| 08 Nov 2024 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 06 Nov 2024 | Sale | 1,000 | 59.94 | 59,940 | D |
| 04 Oct 2024 20:02 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 02 Oct 2024 | Sale | 5,740 | 56.16 | 322,358 | D |
| 04 Oct 2024 20:02 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 02 Oct 2024 | Sale | 925 | 56.86 | 52,596 | D |
| 04 Oct 2024 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 02 Oct 2024 | Sale | 30,288 | 56.07 | 1,698,248 | D |
| 04 Oct 2024 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 02 Oct 2024 | Sale | 9,712 | 56.74 | 551,059 | D |
| 06 Sep 2024 20:03 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 04 Sep 2024 | Sale | 787 | 48.06 | 37,823 | D |
| 06 Sep 2024 20:03 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 04 Sep 2024 | Sale | 5,878 | 47.49 | 279,146 | D |
| 06 Sep 2024 20:02 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 04 Sep 2024 | Sale | 14,359 | 48.23 | 692,535 | D |
| 06 Sep 2024 20:02 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 04 Sep 2024 | Sale | 25,641 | 47.28 | 1,212,306 | D |
| 23 Aug 2024 20:05 | APGE | Apogee Therapeutics Inc | HENDERSON JANE | Chief Financial Officer | 23 Aug 2024 | Sale | 6,000 | 48.26 | 289,560 | D |
| 09 Aug 2024 20:05 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 07 Aug 2024 | Sale | 670 | 42.56 | 28,515 | D |
| 09 Aug 2024 20:05 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 07 Aug 2024 | Sale | 142 | 41.09 | 5,835 | D |
| 09 Aug 2024 20:05 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 07 Aug 2024 | Sale | 6,523 | 40.47 | 263,986 | D |
| 09 Aug 2024 20:05 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 07 Aug 2024 | Sale | 100 | 42.17 | 4,217 | D |
| 09 Aug 2024 20:05 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 07 Aug 2024 | Sale | 7,667 | 41.52 | 318,334 | D |
| 09 Aug 2024 20:05 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 07 Aug 2024 | Sale | 32,233 | 40.4 | 1,302,213 | D |
| 05 Jul 2024 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 05 Jul 2024 | Sale | 15,000 | 37.26 | 558,900 | D |
| 05 Jul 2024 20:01 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 03 Jul 2024 | Sale | 2,143 | 38.16 | 81,777 | D |
| 05 Jul 2024 20:01 | APGE | Apogee Therapeutics Inc | DAMBKOWSKI CARL | Chief Medical Officer | 03 Jul 2024 | Sale | 3,852 | 37.29 | 143,641 | D |
| 17 Jul 2023 20:00 | APGE | Apogee Therapeutics Inc | SHAH NIMISH P | Director | 13 Jul 2023 | Purchase | 1,750,000 | 17 | 29,750,000 | I |
| 17 Jul 2023 20:00 | APGE | Apogee Therapeutics Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director | 13 Jul 2023 | Purchase | 892,529 | 17 | 15,172,993 | I |
| 17 Jul 2023 20:00 | APGE | Apogee Therapeutics Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director | 13 Jul 2023 | Purchase | 1,992,734 | 17 | 33,876,478 | I |
| 17 Jul 2023 20:00 | APGE | Apogee Therapeutics Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director | 13 Jul 2023 | Purchase | 55,913 | 17 | 950,521 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)